Triple

T4116552
Position Surface form Disambiguated ID Type / Status
Subject Paul Ryan E90304 entity
Predicate boardMemberOf P10 FINISHED
Object SHINE Medical Technologies
SHINE Medical Technologies is a U.S.-based nuclear technology company focused on producing medical isotopes and developing fusion-based systems for medicine, industry, and clean energy.
 E412373 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: SHINE Medical Technologies | Statement: [Paul Ryan, boardMemberOf, SHINE Medical Technologies]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: SHINE Medical Technologies
Context triple: [Paul Ryan, boardMemberOf, SHINE Medical Technologies]
  • A. Boston Scientific
    Boston Scientific is a global medical technology company known for developing and manufacturing minimally invasive medical devices, particularly in cardiology and other interventional specialties.
  • B. Medtronic
    Medtronic is a global medical technology company known for developing and manufacturing devices and therapies to treat a wide range of chronic diseases and conditions.
  • C. Abbott Vascular
    Abbott Vascular is a medical device division of Abbott Laboratories that specializes in cardiovascular products such as stents, catheters, and other vascular intervention technologies.
  • D. Heptares Therapeutics
    Heptares Therapeutics is a biopharmaceutical company specializing in the discovery and development of medicines targeting G protein-coupled receptors (GPCRs) using its proprietary structure-based drug design technologies.
  • E. Edwards Lifesciences
    Edwards Lifesciences is a global medical technology company best known for its innovations in heart valves and critical care monitoring systems.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: SHINE Medical Technologies
Triple: [Paul Ryan, boardMemberOf, SHINE Medical Technologies]
Generated description
SHINE Medical Technologies is a U.S.-based nuclear technology company focused on producing medical isotopes and developing fusion-based systems for medicine, industry, and clean energy.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: SHINE Medical Technologies
Target entity description: SHINE Medical Technologies is a U.S.-based nuclear technology company focused on producing medical isotopes and developing fusion-based systems for medicine, industry, and clean energy.
  • A. Boston Scientific
    Boston Scientific is a global medical technology company known for developing and manufacturing minimally invasive medical devices, particularly in cardiology and other interventional specialties.
  • B. Medtronic
    Medtronic is a global medical technology company known for developing and manufacturing devices and therapies to treat a wide range of chronic diseases and conditions.
  • C. Abbott Vascular
    Abbott Vascular is a medical device division of Abbott Laboratories that specializes in cardiovascular products such as stents, catheters, and other vascular intervention technologies.
  • D. Heptares Therapeutics
    Heptares Therapeutics is a biopharmaceutical company specializing in the discovery and development of medicines targeting G protein-coupled receptors (GPCRs) using its proprietary structure-based drug design technologies.
  • E. Edwards Lifesciences
    Edwards Lifesciences is a global medical technology company best known for its innovations in heart valves and critical care monitoring systems.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69aed95c080881908125e30c5dcdc6f8 completed March 9, 2026, 2:29 p.m.
NER Named-entity recognition batch_69af01f347f8819080dd250398474d7e completed March 9, 2026, 5:22 p.m.
NED1 Entity disambiguation (via context triple) batch_69b56b90054081908a51c366c6fe51d7 completed March 14, 2026, 2:07 p.m.
NEDg Description generation batch_69b56c0a3b1c81908ae4c630c6881c1c completed March 14, 2026, 2:09 p.m.
NED2 Entity disambiguation (via description) batch_69b56c94df3481908d2f4a3976fb775b completed March 14, 2026, 2:11 p.m.
Created at: March 9, 2026, 3:41 p.m.